Hillebrand M. | Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
スポンサーリンク
概要
- HILLEBRAND M. J. X.の詳細を見る
- 同名の論文著者
- Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Instituteの論文著者
関連著者
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Hillebrand M.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Huitema A.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Huitema A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
ROSING H.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
BEIJNEN J.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Jimeno J.
Pharma Mar S.a. Research And Development
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Beijnen J.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Floriano P.
Pharmamar S.a. Research And Development
-
BULT Auke
Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University
-
Bult Auke
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
HILLEBRAND M.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute
-
GOMEZ A.
Pharma Mar, S.A., Research and Development
-
FAIRCLOTH G.
Pharma Mar, S.A., Research and Development
-
CAMERON L.
Pharma Mar, S.A., Research and Development
-
HENRAR R.
EORTC-New Drug Development Office
-
VERMORKEN J.
Department of Medical Oncology, University Hospital Antwerpen
-
BULT A.
Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrecht
-
Faircloth G.
Pharma Mar S.a. Research And Development
-
Vermorken J.
Department Of Medical Oncology University Hospital Antwerpen
-
LANKHEET A.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LANGENBERG M.
Department of Medical Oncology, University Medical Center Utrecht
-
VOEST E.
Department of Medical Oncology, University Medical Center Utrecht
-
SCHELLENS J.
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
CROMMENTUYN K.
Department of Pharmacy and Pharmacology, Slotervaart Hospital
-
Cameron L.
Pharma Mar S.a. Research And Development
-
Voest E.
Department Of Medical Oncology University Medical Center Utrecht
-
Lankheet A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Langenberg M.
Department Of Medical Oncology University Medical Center Utrecht
-
Crommentuyn K.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
Gomez A.
Pharma Mar S.a. Research And Development
著作論文
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry